Helix BioPharma Corp. (HBP.TO)

CAD 1.0

(5.26%)

Long Term Debt Summary of Helix BioPharma Corp.

  • Helix BioPharma Corp.'s latest annual long term debt in 2024 was - CAD , down 0.0% from previous year.
  • Helix BioPharma Corp.'s latest quarterly long term debt in 2024 Q3 was - CAD , down 0.0% from previous quarter.
  • Helix BioPharma Corp. reported annual long term debt of - CAD in 2023, down 0.0% from previous year.
  • Helix BioPharma Corp. reported annual long term debt of - CAD in 2022, down -100.0% from previous year.
  • Helix BioPharma Corp. reported quarterly long term debt of - CAD for 2024 Q1, down 0.0% from previous quarter.
  • Helix BioPharma Corp. reported quarterly long term debt of - CAD for 2024 Q3, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Helix BioPharma Corp. (2024 - 2007)

Historical Annual Long Term Debt of Helix BioPharma Corp. (2024 - 2007)

Year Long Term Debt Long Term Debt Growth
2024 - CAD 0.0%
2023 - CAD 0.0%
2022 - CAD -100.0%
2021 1.58 Million CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2015 - CAD 0.0%
2014 - CAD 0.0%
2013 - CAD 0.0%
2012 - CAD 0.0%
2011 - CAD 0.0%
2010 - CAD 0.0%
2009 - CAD 0.0%
2008 - CAD 0.0%
2007 - CAD 0.0%

Peer Long Term Debt Comparison of Helix BioPharma Corp.

Name Long Term Debt Long Term Debt Difference
Appili Therapeutics Inc. 875.2 Thousand CAD 100.0%
Eupraxia Pharmaceuticals Inc. - CAD NaN%
Microbix Biosystems Inc. 6.37 Million CAD 100.0%
Medicenna Therapeutics Corp. - CAD NaN%
Satellos Bioscience Inc. - CAD NaN%
Oncolytics Biotech Inc. 290 Thousand CAD 100.0%
Sernova Corp. - CAD NaN%